表面素诱导的巨细胞调节的分子基础及其对与药物相关的骨缩的影响
Yuki Kodama-Maruyama1, Hiroki Tsurushima2, Ayaka Koga1,3
1Division of Infections and Molecular Biology, Department of Advanced Pathophysiological Science, Kyushu Dental University, Kitakyushu 803-8580, Fukuoka, Japan.
International journal of molecular sciences
|February 13, 2026
概括
表面素是一种天然化合物,在治疗与药物相关的下巴骨硬化 (MRONJ) 中表现有前途. 它通过调节关键的免疫路径,有效地减少炎症和骨亡,为这种困难的疾病提供了潜在的新疗法策略.
科学领域:
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
背景情况:
- 与药物相关的骨 (MRONJ) 是一种严重的疾病,治疗选择有限.
- 表面活性素是来自Bacillus subtilis的生物表面活性剂,具有抗炎和抗菌特性.
- 牙周病原体如Aggregatibacter actinomycetemcomitans可以通过脂多糖 (LPS) 诱导加剧MRONJ.
研究的目的:
- 为了研究表面素对巨细胞中LPS诱导的免疫反应的影响.
- 阐明表面素调节这些反应的分子机制.
- 在MRONJ的体内模型中评估表面素的治疗潜力.
主要方法:
- 反转录定量聚合酶连锁反应 (RT-qPCR) 来评估IL-6基因表达.
- 西部斑点分析以检查JNK-c-Jun-AP-1和JAK/STAT信号通路的激活.
- 在体内MRONJ模型来评估表面素治疗的疗效.
主要成果:
- 表面素显著抑制LPS诱导的IL-6表达和分泌,以度依赖的方式.
- 表面素抑制了JNK-c-Jun-AP-1轴和JAK/STAT信号通路的激活.
- 在体内,在MRONJ模型中,表面素的联合治疗显著减少了LPS诱导的骨坏死.
结论:
- 表面素有效调节对LPS的免疫反应,减少巨细胞中IL-6的产生.
- 表面素在MRONJ的治疗效果是由JNK-c-Jun-AP-1和JAK/STAT通路的下调调的介导.
- 表面素显示出作为一种新型治疗剂的显著潜力,用于管理与药物相关的骨.
关键词:
AP-1 AP-1 AP-1 AP-1 AP-1 AP-1 AP-1 AP-1 AP-1 AP-1 AP-1 AP-1 AP-1 AP-1 AP-1 AP-1 AP-1 AP-1 AP-1 AP-1 AP-1 AP-1 AP-1 AP-1 AP-1 AP-1 AP-1 AP-1 AP-1 AP-1 AP-1 AP-1 AP-1 AP-1 AP-1在IL-6的研究中,IL-6被认为是IL-6的基因.这就是JAK/STAT.这就是MAPKK的意思.一个子,一个子表面的物质是表面的物质更多相关视频
09:32Drug-Induced Senescence in Liver Cells Promotes M2 Macrophage Polarization: Implications for Tyrosine Kinase Inhibitor-Associated Hepatotoxicity
Published on: October 17, 2025
531
08:52Neuron-Macrophage Co-cultures to Activate Macrophages Secreting Molecular Factors with Neurite Outgrowth Activity
Published on: March 30, 2018
9.4K
相关概念视频
03:00Molecular Chaperones and Protein Folding
19.9K
The native conformation of a protein is formed by interactions between the side chains of its constituent amino acids. When the amino acids cannot form these interactions, the protein cannot fold by itself and needs chaperones. Notably, chaperones do not relay any additional information required for the folding of polypeptides; the native conformation of a protein is determined solely by its amino acid sequence. Chaperones catalyze protein folding without being a part of the folded protein.
The...
The...
19.9K
01:30Pulmonary Hypertension: Classification and Pathogenesis
671
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
671
01:20Asthma: Pathogenesis and Management
1.4K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.4K
01:23Cystic Fibrosis: Pathogenesis
896
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
896
01:23Inhaled Medications
833
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
833
01:20COPD: Pathogenesis and Clinical Features
1.9K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.9K